scispace - formally typeset
X

Xingyu Jiang

Researcher at Southern University of Science and Technology

Publications -  567
Citations -  32038

Xingyu Jiang is an academic researcher from Southern University of Science and Technology. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 77, co-authored 467 publications receiving 25403 citations. Previous affiliations of Xingyu Jiang include Guangzhou Medical University & Beijing University of Chemical Technology.

Papers
More filters
Journal ArticleDOI

Soft Lithography in Biology and Biochemistry

TL;DR: Soft lithography offers the ability to control the molecular structure of surfaces and to pattern the complex molecules relevant to biology, to fabricate channel structures appropriate for microfluidics, and topattern and manipulate cells.
Journal ArticleDOI

Diverse Applications of Nanomedicine

Beatriz Pelaz, +91 more
- 14 Mar 2017 - 
TL;DR: An overview of recent developments in nanomedicine is provided and the current challenges and upcoming opportunities for the field are highlighted and translation to the clinic is highlighted.
Journal ArticleDOI

The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli.

TL;DR: This investigation would allow the development of antibacterial agents that target the energy-metabolism and transcription of bacteria without triggering the ROS reaction, which may be at the same time harmful for the host when killing bacteria.
Journal ArticleDOI

Advances in three-dimensional nanofibrous macrostructures via electrospinning

TL;DR: In this paper, the authors summarized and reviewed recent advances in various promising and cutting-edge electrospinning techniques, including multilayering electro-spinning, post-processing after electro spinning, liquid-assisted collection, template assisted collection, porogen-added electro-spinning, and self-assembly.
Journal ArticleDOI

Small Molecule-Capped Gold Nanoparticles as Potent Antibacterial Agents That Target Gram-Negative Bacteria

TL;DR: A new strategy in designing antibacterial agents is illustrated--a series of commercially available compounds, amino-substituted pyrimidines, when presented on gold nanoparticles (NPs), show antibacterial activities against multidrug-resistant clinical isolates, without external sources of energy such as IR.